The molecular basis of premature adrenarche: An hypothesis

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 88, Issue 433, 1999, Pages 60-66

  Miller, Walter L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adrenal gland; Adrenopause; Cytochrome b5; Dehydroepiandrosterone; P450c17; Polycystic ovary syndrome; Premature adrenarche

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; HYDROCORTISONE; PRASTERONE SULFATE; STEROID 17ALPHA MONOOXYGENASE;

ADRENAL CORTEX; ADRENARCHE; CONFERENCE PAPER; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; GONADOTROPIN RELEASE; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; HYDROCORTISONE RELEASE; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PRECOCIOUS PUBERTY; PRIORITY JOURNAL;

ADRENAL GLANDS; CHILD; CYTOCHROME P-450 ENZYME SYSTEM; DEHYDROEPIANDROSTERONE; FEMALE; HUMANS; PHOSPHORYLATION; POLYCYSTIC OVARY SYNDROME; PUBERTY; PUBERTY, PRECOCIOUS;

EID: 0033431824     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (80)

1. Parker LN, Sack J, Fisher DA, O'Dell WD. The adrenarche: prolactin, gonadotropins, adrenal androgens, and cortisol. J Clin Endocrinol Metab 1978; 46: 396-401
2. Sklar CA, Kaplan SL, Grumbach MM. Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. J Clin Endocrinol Metab 1980; 51: 548-56
3. Apter D, Pakarinen A, Hammond GL, Vihko R. Adrenocortical function in puberty. Acta Paediatr Scand 1979; 68: 599-604
4. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984; 59: 551-5
5. Morales AJ, Nolan JJ, Nelson JC, Yen SSC. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994; 78: 1360-7
6. Baulieu EE. Dehydroepiandrosterone (DHEA): a fountain of youth? J Clin Endocrinol Metab 1996; 81: 3147-51
7. Cutler GB, Glenn M, Bush M, Hodgen GD, Graham CE, Loriaux DL. Adrenarche: a survey of rodents, domestic animals and primates. Endocrinology 1978; 103: 2112-8
8. Castracane VD, Cutler GB Jr, Loriaux DL. Pubertal endocrinology of the baboon: adrenarche. Am J Physiol 1981; 241: E305-9
9. Smail PJ, Faiman C, Hobson WC, Fuller GB, Winter JSD. Further studies on adrenarche in nonhuman primates. Endocrinology 1982; 111: 844-8
10. Parker LN, Odell WD. Evidence for existence of cortical androgen-stimulating hormone. Am J Physiol 1979; 236: E616-20
11. Anderson DC. The adrenal androgen-stimulating hormone does not exist. Lancet 1980; 2: 454-6
12. Whitfeld PL, Seeburg PH, Shine J. The human pro-opiomela nocortin gene: organization, sequence, and interspersion with repetitive DNA. DNA 1982; 1: 133-43
13. Parker L, Lifrak E, Shively J, Lee T, Kaplan B, Walker P, et al. Human adrenal gland cortical androgen-stimulating hormone (CASH) is identical with a portion of the joining peptide of pituitary pro-opiomelanocortin (POMC). 71st Annual Meeting of the Endocrine Society; 1989; A299 (abstract)
14. Mellon SH, Shively JE, Miller WL. Human proopiomelanocortin (79-96), a proposed androgen stimulatory hormone, does not affect steroidogenesis in cultured human fetal adrenal cells. J Clin Endocrinol Metab 1991; 72: 19-22
15. Penhoat A, Sanchez P, Jaillard C, Langlois D, Begeot M, Saez JM. Human proopiomelanocortin (79-96), a proposed cortical androgen stimulating hormone, does not affect steroidogenesis in cultured human adult adrenal cells. J Clin Endocrinol Metab 1991; 72: 23-6
16. Robinson P, Bateman A, Mulay S, Spencer SJ, Jaffe RB, Solomon S, et al. Isolation and characterization of three forms of joining peptide from adult pituitaries: lack of adrenal androgen stimulating activity. Endocrinology 1991; 129: 859-67
17. McLean M, Davies JJ, Woods R, Lowry PJ, Smith R. A placental clock controlling the length of human pregnancy. Nat Med 1995; 1: 460-3
18. Smith R, Mesiano S, Chan E-C, Brown S, Jaffe RB. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metab 1998; 83: 2916-20
19. Fujieda K, Faiman C, Reyes FI, Winter JSD. The control of steroidogenesis by human fetal adrenal cells in culture. I. Responses to ACTH. J Clin Endocrinol Metab 1981; 53: 34-8
20. Couch RM, Muller J, Winter JSD. Regulation of the activities of 17α-hydroxylase and 17,20-desmolase in the human adrenal cortex: kinetic analysis and inhibition by endogenous steroids. J Clin Endocrinol Metab 1986; 63: 613-8
21. Schiebinger RJ, Albertson BD, Cassorla FG, Bowyer DW, Geelhoed GW, Cutler GB, et al. The developmental changes in plasma adrenal androgens during infancy and adrenarche are associated with changing activities of adrenal microsomal 17-hydroxylase and 17,20 desmolase, J Clin Invest 1981; 67: 1177-82
22. Liu C, Laughlin GA, Fischer VG, Yen SSC. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: evidence for a reduced 17,20-desmolase enzymatic activity. J Clin Endocrinol Metab 1990; 71: 900-6
23. Miller WL. Molecular biology of steroid hormone synthesis. Endocr Rev 1988; 9: 295-318
24. Stocco DM, Clark BJ. Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 1996; 17: 221-44
25. Lin D, Sugawara T, Strauss III JF, Clark BJ, Stocco DM, Saenger P, et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995; 267: 1828-31
26. Bose HS, Sugawara T, Strauss III JF, Miller WL. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med 1996; 335: 1870-8
27. Cherradi N, Rossier MF, Vallotton MB, Timberg R, Friedberg I, Orly J, et al. Submitochondrial distribution of three key steroidogenic proteins (steroidogenic acute regulatory protein and cytochrome P450scc and 3β-hydroxysteroid dehydrogenase isomerase enzymes) upon stimulation by intracellular calcium in adrenal glomerulosa cells. J Biol Chem 1997; 272: 7899-907
28. Lee TC, Miller WL, Auchus RJ. Medroxyprogesterone acetate and dexamethasone are competitive inhibitors of different human steroidogenic enzymes. J Clin Endocrinol Metab 1999; 84: 2104-10
29. 106 and P450 reductase. Endocrinology 1993; 132: 2498-506
30. 5 augments the 17,20 lyase activity of human P450c17 without direct electron transfer. J Biol Chem 1998; 273: 3158-65
31. Miller WL. Pathophysiology, genetics and treatment of hyper-androgenism. Pediatr Clin North Am 1997; 44: 375-95
32. Miller WL. Early steps in androgen biosynthesis: from cholesterol to DHEA. Baillieres Clin Endocrinol Metab 1998; 12: 67-81
33. Rhéaume E, Simard J, Morel Y, Mebarki F, Zachmann M, Forest MG, et al. Congenital adrenal hyperplasia due to point mutations in the type II 3β-hydroxysteroid dehydrogenase gene. Nat Genet 1992; 1: 239-45
34. Morel Y, Mébarke F, Rhéaume E, Sanchez R, Forest MG, Simard J. Structure-function relationships of 3β-hydroxysteroid dehydrogenase: contribution made by the molecular genetics of 3β-hydroxysteroid dehydrogenase deficiency. Steroids 1997; 62: 176-84
35. Sakai Y, Yanase T, Hara T, Takayanagi R, Haji M, Nawata H. Mechanism of abnormal production of adrenal androgens in patients with adrenocortical adenomas and carcinomas. J Clin Endocrinol Metab 1994; 78: 36-40
36. Voutilainen R, Ilvesmaki V, Miettinen PJ. Low expression of 3β-hydroxy-5-ene steroid dehydrogenase gene in human fetal adrenals in vivo; adrenocorticotropin and protein kinase C-dependent regulation in adrenocortical cultures. J Clin Endocrinol Metab 1991; 72: 761-7
37. Mesiano S, Coulter CL, Jaffe RB. Localization of cytochrome P450 cholesterol side-chain cleavage, cytochrome P450 17α-hydroxylase/17,20 lyase, and 3β-hydroxysteroid dehydrogenase-isomerase steroidogenic enzymes in human and rhesus monkey fetal adrenal glands: reappraisal of functional zonation. J Clin Endocrinol Metab 1993; 77: 1184-9
38. Cavallero C, Chiappino G. Histochemistry of steroid-3β-ol dehydrogenase in the human adrenal cortex. Experientia 1962; 18: 119-20
39. Sasano H, Mason JI, Sasano N, Nagura H. Immunolocalization of 3β-hydroxysteroid dehydrogenase in human adrenal cortex and its disorders. Endocr Pathol 1990; 1: 94-101
40. Endoh A, Kristiansen SB, Casson PR, Buster JE, Hornsby PJ, The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3β-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab 1996; 81: 3558-65
41. Gell JS, Carr BR, Sasano H, Atkins B, Margraf L, Mason JI, et al. Adrenarche results from development of a 3β-hydroxysteroid dehydrogenase-deficient adrenal reticularis. J Clin Endocrinol Metab 1998; 83: 3695-701
42. Dardis A, Saraco N, Rivarola MA, Belgorosky A. Decrease in the expression of the 3β-hydroxysteroid dehydrogenase gene in human adrenal tissue during prepuberty and early puberty: implications for the mechanism of adrenarche. Pediatr Res 1999; 45: 384-8
43. Rich BH, Rosenfield RL, Luckey AW, Helke JC, Otto P. Adrenarche: changing adrenal response to adrenocorticotropin. J Clin Endocrinol Metab 1981; 52: 1129-36
44. Zachmann M, Vollmin JA, Hamilton W, Prader A. Steroid 17,20 desmolase deficiency: a new cause of male pseudohermaphroditism. Clin Endocrinol (Oxf) 1972; 1: 369-85
45. Goebelsmann U, Zachmann M, Davajan V, Israel R, Mestman JH, Mishell DR. Male pseudohermaphroditism consistent with 17,20-desmolase deficiency. Gynecol Invest 1976; 7: 138-56
46. Nakajin S, Shively JE, Yuan P, Hall PF. Microsomal cytochrome P450 from neonatal pig testis: two enzymatic activities (17α-hydroxylase and C17,20-lyase) associated with one protein. Biochemistry 1981; 20: 4037-42
47. 17,20 lyase cytochrome P450. J Biol Chem 1984; 259: 3971-6
48. Chung B, Picado-Leonard J, Haniu M, Bienkowski M, Hall PF, Shivley JE, et al. Cytochronie P450c17 (steroid 17α-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc Natl Acad Sci USA 1987; 84: 407-11
49. Picado-Leonard J, Miller WL. Cloning and sequence of the human gene encoding P450c17 (steroid 17α-hydroxylase/17,20 lyase): similarity to the gene for P450c21. DNA 1987; 6:439-48
50. 106 → Pro causes 17α-hydroxylase deficiency. J Biol Chem 1991; 266: 15992-8
51. Yanagibashi K, Hall PF. Role of electron transport in the regulation of the lyase activity of C-21 side-chain cleavage P450 from porcine adrenal and testicular microsomes. J Biol Chem 1986; 261: 8429-33
52. 21 side-chain cleavage). Biochem Biophys Res Commun 1982; 108: 454-60
53. 5 potentiation of cytochrome P-450 catalytic activity demonstrated by a vaccinia virus-mediated in situ reconstitution system. Proc Natl Acad Sci USA 1990; 87: 5425-9
54. 5 in adrenal microsomal steroidogenesis. J Steroid Biochem Mol Biol 1992; 42: 57-64
55. Picado-Leonard J, Miller WL. Homologous sequences in steroidogenic enzymes, steroid receptors and a steroid binding protein suggest a consensus steroid-binding sequence. Mol Endocrinol 1988; 2: 1145-50
56. Kitamura M, Buczko E, Dufau ML. Dissociation of hydroxylase and lyase activities by site-directed mutagenesis of the rat P450-17α. Mol Endocrinol 1991; 5: 1373-80
57. Hasemann CA, Kurumbail RG, Boddupalli SS, Peterson JA, Deisenhofer J. Structure and function of cytochromes P450: a comparative analysis of three crystal structures. Structure 1995; 2: 41-62
58. Lin D, Zhang L, Chiao E, Miller WL. Modeling and mutagenesis of the active site of human P450c17. Mol Endocrinol 1994; 8: 392-402
59. Auchus RJ, Miller WL. Molecular modeling of human P450c17 (17α-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations. Mol Endocrinol 1999; 13: 1169-82
60. Geller DH, Auchus RJ, Mendonça BB, Miller WL. The genetic and functional basis of isolated 17,20 lyase deficiency. Nat Genet 1997; 17: 201-5
61. Biason-Lauber A, Leiberman E, Zachmann M. A single amino acid substitution in the putative redox partner-binding site of P450c17 as cause of isolated 17,20 lyase deficiency. J Clin Endocrinol Metab 1997; 82: 3807-12
62. 5. Mol Endocrinol 1999; 13: 167-75
63. 5 in the human adrenal gland and in adrenocortical adenomas from patients with Cushing syndrome. Endocr J 1998; 45: 89-95
64. Zhang L, Rodriguez H, Ohno S, Miller WL. Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and for the polycystic ovary syndrome. Proc Natl Acad Sci USA 1995; 92: 10619-23
65. Auchus RJ, Geller DH, Lee TC, Miller WL. The regulation of human P450c17 activity: relationship to premature adrenarche and the polycystic ovary syndrome. Trends Endo Metab 1998; 9: 47-50
66. Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med 1995; 98(Suppl 1A): 33S-39S
67. Takayama S, White MF, Kahn CR. Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J Biol Chem 1998; 263: 3440-7
68. Chin JE, Dickens M, Tavare JM, Roth RA. Overexpression of protein kinase C isozymes α, βI, λ and ε in cells overexpressing the insulin receptor. Effects on receptor phosphorylation and signaling. J Biol Chem 1993; 268: 6338-47
69. Dunaif A, Xia J, Book C-B, Schenker E, Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. J Clin Invest 1995; 96: 801-10
70. Ferriman D, Purdie AW. The inheritance of polycystic ovarian disease and possible relationship to premature balding. Clin Endocrinol (Oxf) 1979; 1: 291-9
71. Govind A, Obhrai MS, Clayton RN. Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab 1999; 84: 38-43
72. Legro RS, Driscoll D, Strauss III JF, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 1998; 95: 14956-60
73. Ibáñez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinyé M, et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993; 76: 1599-1603
74. Ibáñez L, Potau N, Zampolli M, Rique S, Saenger P, Carrascosa A. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 1997; 82: 2283-8
75. Ibáñez L, Potau N, Zampolli M, Prat N, Virdis R, Vicens-Calvet E, et al. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1996; 81: 1237-43
76. Oppenheimer E, Linder B, DiMartino-Nardi J. Decreased insulin sensitivity in prepubertal girls with premature pubarche and acanthosis nigricans. J Clin Endocrinol Metab 1995; 80: 614-8
77. Voutilainen R, Miller WL. Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain cleavage enzyme, P450scc, in human steroidogenic tissues. Proc Natl Acad Sci USA 1987; 84: 1590-4
78. Voutilainen R, Miller WL. Developmental and hormonal regulation of mRNAs for insulin-like growth factor and steroidogenic enzymes in human fetal adrenals and gonads. DNA 1988; 7: 9-15
79. Mesiano S, Mellon SH, Jaffe RB. Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland. J Clin Endocrinol Metab 1993; 76: 968-76
80. Townsend S, Dallman MF, Miller WL. Rat insulin-like growth factors-I and -II mRNAs are unchanged during compensatory adrenal growth but decrease during ACTH-induced adrenal growth. J Biol Chem 1990; 265: 22117-22